TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Without Edible Marijuana Legalized, Will Demand Fall Short of Expectations?
Investing
Forward-Looking Revenue Estimates for the Marijuana Industry
Investing
Canopy Growth Corp. Is Wheeling and Dealing, and Investors Love it
Investing
Why Investors May Be the Ones Who Are High
Stocks for Beginners
New Investors: Should Canopy Growth Corp. Be in Your TFSA?
Investing
Should You Buy Aphria Inc. Ahead of Earnings?
Investing
Is Canopy Growth Corp. Overvalued?
Investing
Canopy Growth Corp.: Is the Stock a Must-Buy After the New Brunswick Deal?
Tech Stocks
Do Marijuana Stocks Have More Growth Potential Than Tech Stocks?
Investing
3 Reasons to Remain Skeptical About Marijuana Stocks
Investing
You Could Do a Lot Worse Than Owning This $10 Portfolio